In 2007, Pfizer announced it would leave its University of Michigan facility where its pharmaceutical labs had created drugs such as Lipitor.
University officials decided to purchase the Pfizer property for $108 million and increase the university's research space by 10% when no other buyers stepped forward.
The campus will be used by the U-M Medical School and other departments for research in fields including health sciences, pharmaceuticals, biotech, alternative energy, and nanotechnology and could create 2,000 high-paying research jobs within the next 10 years.